This document presents the case of a 30-year-old woman with a known history of invasive mole who is undergoing chemotherapy. She has a history of irregular bleeding and multiple D&Cs. Her most recent beta-HCG levels indicated a significant drop in tumor marker levels in response to six cycles of chemotherapy. Her physical examination was normal and laboratory results were stable. She will continue chemotherapy on an outpatient basis to further treat her invasive mole.